305 related articles for article (PubMed ID: 25234198)
1. Intraoperative diagnosis of central compartment lymph node metastasis predicts recurrence of patients with papillary thyroid carcinoma and clinically node-negative lateral neck and may guide extent of initial surgery.
Lee CW; Gong G; Roh JL
World J Surg; 2015 Jan; 39(1):194-202. PubMed ID: 25234198
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
3. Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography.
Sugitani I; Fujimoto Y; Yamada K; Yamamoto N
World J Surg; 2008 Nov; 32(11):2494-502. PubMed ID: 18784956
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic lymph node dissection in papillary thyroid carcinoma: is there a place for lateral neck dissection?
Ducoudray R; Trésallet C; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
World J Surg; 2013 Jul; 37(7):1584-91. PubMed ID: 23564213
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
6. Central lymph nodes in frozen sections can effectively guide extended lymph node resection for papillary thyroid carcinoma.
Peng L; Zheng X; Xue Y; Huang C; Su X; Yu S
Ann Med; 2023; 55(2):2286337. PubMed ID: 38061392
[TBL] [Abstract][Full Text] [Related]
7. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
[TBL] [Abstract][Full Text] [Related]
8. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
9. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
Ryu YJ; Cho JS; Yoon JH; Park MH
World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
[TBL] [Abstract][Full Text] [Related]
10. The utility of sentinel Lymph node biopsy in the lateral neck in papillary thyroid carcinoma.
Yan XQ; Ma ZS; Zhang ZZ; Xu D; Cai YJ; Wu ZG; Zheng ZQ; Xie BJ; Cao FL
Front Endocrinol (Lausanne); 2022; 13():937870. PubMed ID: 35957824
[TBL] [Abstract][Full Text] [Related]
11. Total thyroidectomy with therapeutic level II-IV neck dissection for papillary thyroid carcinoma: level VI recurrence patterns.
Carmel-Neiderman NN; Duek I; Amsterdam D; Wengier A; Kuzmenko B; Ringel B; Warshavsky A; Shapira U; Horowitz G; Izkhakov E; Fliss DM
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3449-3455. PubMed ID: 32488373
[TBL] [Abstract][Full Text] [Related]
12. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
Ryu YJ; Cho JS; Park MH; Yoon JH
BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
[TBL] [Abstract][Full Text] [Related]
13. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
[TBL] [Abstract][Full Text] [Related]
15. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Implications of Lymph Node Yield in Central and Lateral Neck Dissections for Well-Differentiated Papillary Thyroid Carcinoma.
Heaton CM; Chang JL; Orloff LA
Thyroid; 2016 Mar; 26(3):434-40. PubMed ID: 26825749
[TBL] [Abstract][Full Text] [Related]
17. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
18. Papillary thyroid cancer: controversies in the management of neck metastasis.
Davidson HC; Park BJ; Johnson JT
Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855
[TBL] [Abstract][Full Text] [Related]
19. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
20. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
